A detailed history of Motiv8 Investments LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Motiv8 Investments LLC holds 69,245 shares of HRTX stock, worth $165,495. This represents 0.07% of its overall portfolio holdings.

Number of Shares
69,245
Previous 77,646 10.82%
Holding current value
$165,495
Previous $155 Million 31.43%
% of portfolio
0.07%
Previous 0.1%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

SELL
$1.06 - $2.12 $8,905 - $17,810
-8,401 Reduced 10.82%
69,245 $106 Million
Q3 2024

Oct 24, 2024

SELL
$1.73 - $3.67 $58 - $124
-34 Reduced 0.04%
77,646 $155 Million
Q2 2024

Aug 06, 2024

SELL
$2.32 - $3.86 $85 - $142
-37 Reduced 0.05%
77,680 $272 Million
Q1 2024

May 30, 2024

SELL
$1.71 - $3.06 $23 - $42
-14 Reduced 0.02%
77,717 $215 Million
Q4 2023

May 30, 2024

BUY
$0.54 - $1.82 $41,974 - $141,470
77,731 New
77,731 $132 Million

Others Institutions Holding HRTX

About HERON THERAPEUTICS, INC.


  • Ticker HRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,774,000
  • Market Cap $284M
  • Description
  • Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...
More about HRTX
Track This Portfolio

Track Motiv8 Investments LLC Portfolio

Follow Motiv8 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Motiv8 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Motiv8 Investments LLC with notifications on news.